PAGE4

Mutation & survival
SurvivalMutationKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, PAGE4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PAGE4 data layer compared with 20 for mass-spec protein and 1 for mass-spec protein.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher PAGE4 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated PAGE4 expression acts as an unfavorable survival marker.

STAD and HNSC are the cancer types where PAGE4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
STADOSMedianAll0.0960.688<.00124view →
HNSCOSMedianAll0.1510.685.0073view →
Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PAGE4–STAD (OS)

Kaplan–Meier survival curve for PAGE4 mutant vs wild-type samples in STAD.

Open the STAD breakdown →

Exploration